Chief of the Division of Surgical Oncology at the University of Pittsburgh Medical Center, David L. Bartlett, MD, completed his undergraduate studies at Rice University in Texas and earned his medical degree from the University of Texas Medical School. Bartlett completed his residency in surgery at the Hospital of the University of Pennsylvania and fellowships in surgery and surgical oncology at Memorial Sloan-Kettering Cancer Center in New York. Research fellowships completed by Dr. Bartlett include one at the M.D. Anderson Hospital, Department of Developmental Therapeutics in Houston, Texas and another in the Department of Surgery at the Hospital of the University of Pennsylvania, Harrison Department of Surgical Research.

Dr. Bartlett's interests include all types of surgical oncology, particularly the management of advanced, complex abdominal malignancies such as peritoneal mesothelioma. He is experienced in a wide variety of surgical techniques including complex liver resections, radiofrequency ablation, infusion chemotherapy via an implantable pump and isolated hyperthermic liver perfusion, an experimental procedure for patients with unresectable tumors confined to their liver.

As a researcher, Dr. Bartlett has helped developed a technique for the delivery of hyperthermia and chemotherapy directly to the peritoneal cavity as a recirculating perfusion. This novel technique delivers chemotherapy in the operating room to patients with disease confined to the peritoneal cavity. Dr. Bartlett also has a keen interest in the research of gene therapy and has written a variety of articles and papers concerning this approach to treating a variety of cancers.

Dr. Bartlett is a member of the American Medical Association, the Society of Surgical Oncology, and the American Society of Gene Therapy. In addition, he has served as a Senior Investigator at the National Cancer Institute Surgery Branch, which conducts laboratory and clinical research aimed at improving the management of patients with cancer.

Contact Information:
Hillman Cancer Center
5115 Centre Avenue
Pittsburgh, PA 15232
Phone: 412-692-2852

Doctor Match Program

One of the most important factors in improving a mesothelioma patient's life expectancy is their selection of doctor and treatment facility. Asbestos.com's Doctor Match Program is now helping patients get matched with top mesothelioma specialists around the country. If you wish to take advantage of this free service please call us at (800) 549-0544 or click here visit our doctor match page.

Two must read books for anyone who has or who is caring for someone with mesothelioma.

Get a Free Copy of Lean on Me or 100 Questions & Answers About Mesothelioma.

Asbestos.com has experienced navy veterans on staff to assist veterans in answering questions about applying for asbestos-related VA Claims and other benefits.

*Asbestos.com is not affiliated with the
U.S. Department. of Veterans Affairs.

Naval Ships Index
Search through our extensive list of ships that used asbestos-containing products.
(e.g. USS Alabama BB 60)

Get matched with the top mesothelioma specialists in your area.

Learn what foods to eat, which to avoid, and the best supplements for the fight against cancer and chemotherapy recovery.

Pleural Mesothelioma May Have New Biomarker
09/01/2010 - In a recent article published in the online publication Modern Pathology, researchers may have found a new biomarker for malignant pleural mesotheliom..
Mesothelioma-Causing Asbestos May be Banned in Taiwan
08/31/2010 - According to a news report, Taiwan's Environmental Protection Agency (EPA) has plans to phase out the use of asbestos within the next decade. Lin C..
Mesothelioma Risk in Schools Can Be Managed
08/30/2010 - Seven schools in Virginia Beach, Virginia built between 1956 and 1974 have been found to contain a small amount of asbestos in sealants applied to the..